{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:05:39Z","timestamp":1761743139803,"version":"3.28.2"},"reference-count":38,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"DOI":"10.3201\/eid1410.080576","type":"journal-article","created":{"date-parts":[[2008,10,8]],"date-time":"2008-10-08T19:41:27Z","timestamp":1223494887000},"page":"1558-1566","source":"Crossref","is-referenced-by-count":17,"title":["Prophylaxis after Exposure to<i>Coxiella burnetii<\/i>"],"prefix":"10.3201","volume":"14","author":[{"given":"Claire E.","family":"Moodie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert A.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin I.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Swerdlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","published-online":{"date-parts":[[2008,10]]},"reference":[{"key":"key-10.3201\/eid1410.080576-201210011450-R1","unstructured":"Health Protection Agency Center for Infections. Interim guidelines for action in the event of a deliberate release: Q fever. 2005. Version 1.4, revised 2007 Jun 18 [cited 2008 Aug 1]. Available from www.hpa.org.uk\/webw\/HPAweb&HPAwebStandard\/HPAweb_C\/1195733766607?p=1192454969657"},{"key":"key-10.3201\/eid1410.080576-201210011450-R2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1089\/15303660260613747","article-title":"Q fever in humans and animals in the United States.","volume":"2","author":"McQuiston","year":"2002","journal-title":"Vector Borne Zoonotic Dis"},{"key":"key-10.3201\/eid1410.080576-201210011450-R3","first-page":"183","article-title":"Q fever as a biological weapon.","volume":"18","author":"Kagawa","year":"2003","journal-title":"Semin Respir Infect"},{"key":"key-10.3201\/eid1410.080576-201210011450-R4","unstructured":"United States Army Medical Research Institute for Infectious Diseases. Medical management of biological casualities handbook. 5th ed. Frederick (MD): The Institute; 2004."},{"key":"key-10.3201\/eid1410.080576-201210011450-R5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/ije\/16.2.282","article-title":"An important outbreak of human Q fever in a Swiss Alpine valley.","volume":"16","author":"Dupuis","year":"1987","journal-title":"Int J Epidemiol"},{"key":"key-10.3201\/eid1410.080576-201210011450-R6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1001\/jama.1997.03550050061035","article-title":"Clinical recognition and management of patients exposed to biological warfare agents.","volume":"278","author":"Franz","year":"1997","journal-title":"JAMA"},{"key":"key-10.3201\/eid1410.080576-201210011450-R7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/CMR.12.4.518","article-title":"Q fever.","volume":"12","author":"Maurin","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"key-10.3201\/eid1410.080576-201210011450-R8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/00005792-200003000-00005","article-title":"Q fever 1985\u20131998. Clinical and epidemiologic features of 1,383 infections.","volume":"79","author":"Raoult","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"key-10.3201\/eid1410.080576-201210011450-R9","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.2807\/esm.09.12.00499-en","article-title":"Bichat guidelines for the clinical management of Q fever and bioterrorism-related Q fever.","volume":"9","author":"Bossi","year":"2004","journal-title":"Euro Surveill"},{"key":"key-10.3201\/eid1410.080576-201210011450-R10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/j.1467-842X.2003.tb00415.x","article-title":"An economic evaluation of increased uptake in Q fever vaccination among meat and agricultural industry workers following implementation of the National Q Fever Management Program.","volume":"27","author":"Kermode","year":"2003","journal-title":"Aust N Z J Public Health"},{"key":"key-10.3201\/eid1410.080576-201210011450-R11","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/JCM.36.7.1823-1834.1998","article-title":"Diagnosis of Q fever.","volume":"36","author":"Fournier","year":"1998","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid1410.080576-201210011450-R12","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S1473-3099(02)00448-6","article-title":"Q fever\u2014a forgotten disease?","volume":"2","author":"Cutler","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid1410.080576-201210011450-R13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1086\/321889","article-title":"Risks factors and prevention of Q fever endocarditis.","volume":"33","author":"Fenollar","year":"2001","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1410.080576-201210011450-R14","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/S1473-3099(02)00440-1","article-title":"Q fever in children.","volume":"2","author":"Maltezou","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid1410.080576-201210011450-R15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/archinte.159.2.167","article-title":"rditi-Djiane J, Brouqui P. Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine.","volume":"159","author":"Raoult","year":"1999","journal-title":"Arch Intern Med"},{"key":"key-10.3201\/eid1410.080576-201210011450-R16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/qjmed\/hci009","article-title":"Long-term persistence of Coxiella burnetii after acute primary Q fever.","volume":"98","author":"Marmion","year":"2005","journal-title":"QJM"},{"key":"key-10.3201\/eid1410.080576-201210011450-R17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archinte.162.6.701","article-title":"Q fever during pregnancy: diagnosis, treatment, and follow-up.","volume":"162","author":"Raoult","year":"2002","journal-title":"Arch Intern Med"},{"key":"key-10.3201\/eid1410.080576-201210011450-R18","unstructured":"Centers for Disease Control and Prevention. Bioterrorism agents\/diseases [cited 2006 Sep 9]. Available from http:\/\/www.bt.cdc.gov\/agent\/agentlist-category.asp#b"},{"key":"key-10.3201\/eid1410.080576-201210011450-R19","first-page":"98","article-title":"Studies on Q fever in man.","volume":"69","author":"Benenson","year":"1956","journal-title":"Trans Assoc Am Physicians"},{"key":"key-10.3201\/eid1410.080576-201210011450-R20","unstructured":"Byrne WR. Chapter 26: Q fever. In: Zajtchuk R, editor. Textbook of military medicine: medical aspects of chemical and biological warfare. Washington: US Department of the Army, Surgeon General and the Borden Institute; 1997. p. 523\u201337."},{"key":"key-10.3201\/eid1410.080576-201210011450-R21","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1086\/520661","article-title":"Managing Q fever during pregnancy: the benefits of long-term cotrimoxazole therapy.","volume":"45","author":"Carcopino","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1410.080576-201210011450-R22","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/00007435-199509000-00002","article-title":"The cost effectiveness of azithromycin for Chlamydia trachomatis infections in women.","volume":"22","author":"Haddix","year":"1995","journal-title":"Sex Transm Dis"},{"key":"key-10.3201\/eid1410.080576-201210011450-R23","first-page":"7","article-title":"Cost-effectiveness analysis of five different antibiotic regimens for the treatment of uncomplicated Chlamydia trachomatis cervicitis.","volume":"8","author":"Nuovo","year":"1995","journal-title":"J Am Board Fam Pract"},{"key":"key-10.3201\/eid1410.080576-201210011450-R24","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1111\/j.1532-5415.2001.49268.x","article-title":"Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim-sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection.","volume":"49","author":"Gomolin","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"key-10.3201\/eid1410.080576-201210011450-R25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1089\/08892220252779629","article-title":"Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection.","volume":"18","author":"DiRienzo","year":"2002","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key-10.3201\/eid1410.080576-201210011450-R26","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0272-2712(18)30018-0","article-title":"Clinical recognition and management of patients exposed to biological warfare agents.","volume":"21","author":"Franz","year":"2001","journal-title":"Clin Lab Med"},{"key":"key-10.3201\/eid1410.080576-201210011450-R27","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1183\/09031936.03.00099703","article-title":"Coxiella burnetii pneumonia.","volume":"21","author":"Marrie","year":"2003","journal-title":"Eur Respir J"},{"key":"key-10.3201\/eid1410.080576-201210011450-R28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/qjmed\/91.2.105","article-title":"Post-infection fatigue syndrome following Q fever.","volume":"91","author":"Ayres","year":"1998","journal-title":"QJM"},{"key":"key-10.3201\/eid1410.080576-201210011450-R29","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0140-6736(96)91469-5","article-title":"Protracted debility and fatigue after acute Q fever.","volume":"347","author":"Marmion","year":"1996","journal-title":"Lancet"},{"key":"key-10.3201\/eid1410.080576-201210011450-R30","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0954-6111(93)90006-L","article-title":"A large Q fever outbreak in the West Midlands: clinical aspects.","volume":"87","author":"Smith","year":"1993","journal-title":"Respir Med"},{"key":"key-10.3201\/eid1410.080576-201210011450-R31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/00002030-199301000-00012","article-title":"Q fever and HIV infection.","volume":"7","author":"Raoult","year":"1993","journal-title":"AIDS"},{"key":"key-10.3201\/eid1410.080576-201210011450-R32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3109\/00365549709008663","article-title":"Q fever endocarditis in Israel and a worldwide review.","volume":"29","author":"Siegman-Igra","year":"1997","journal-title":"Scand J Infect Dis"},{"key":"key-10.3201\/eid1410.080576-201210011450-R33","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/0003-4819-142-8-200504190-00008","article-title":"Cost-effectiveness of defending against bioterrorism: a comparison of vaccination and antibiotic prophylaxis against anthrax.","volume":"142","author":"Fowler","year":"2005","journal-title":"Ann Intern Med"},{"key":"key-10.3201\/eid1410.080576-201210011450-R34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1128\/AAC.27.3.297","article-title":"Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections.","volume":"27","author":"Sabbaj","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1410.080576-201210011450-R35","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1001\/jama.283.12.1583","article-title":"Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial.","volume":"283","author":"Talan","year":"2000","journal-title":"JAMA"},{"key":"key-10.3201\/eid1410.080576-201210011450-R36","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1016\/j.jinf.2005.05.008","article-title":"Trimethoprim-sulfamethoxazole induced rash and fatal hematologic disorders.","volume":"52","author":"Kocak","year":"2006","journal-title":"J Infect"},{"key":"key-10.3201\/eid1410.080576-201210011450-R37","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1345\/aph.10310","article-title":"Trimethoprim\/sulfamethoxazole-induced toxic epidermal necrolysis.","volume":"35","author":"See","year":"2001","journal-title":"Ann Pharmacother"},{"key":"key-10.3201\/eid1410.080576-201210011450-R38","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3201\/eid1006.020738","article-title":"Airborne infection with Bacillus anthracis\u2014from mills to mail.","volume":"10","author":"Fennelly","year":"2004","journal-title":"Emerg Infect Dis"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/14\/10\/08-0576_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T14:29:59Z","timestamp":1732631399000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/14\/10\/08-0576_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2008,10]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1410.080576","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"type":"print","value":"1080-6040"},{"type":"electronic","value":"1080-6059"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}